Mdm2: keeping p53 under control
- PMID: 9285554
- DOI: 10.1038/sj.onc.1201432
Mdm2: keeping p53 under control
Abstract
The Mdm2 gene is overexpressed in several human tumors. The oncogenic potential of Mdm2 is partially explained by the inhibition of the activity of the tumor suppressor protein p53. Determination of the three-dimensional structure of complexes between Mdm2 and the N-terminal p53 peptide provided a molecular basis for the inhibition of the transcriptional function of p53 by Mdm2. More dramatically, p53 is targeted by Mdm2 for rapid degradation. The Mdm2 gene itself is activated by p53, which gives the opportunity for feed-back control of p53 activity. Keeping p53 under control is most likely the major task of Mdm2 during early development. Recently, evidence was provided for an alternative, p53-independent function of Mdm2.
Similar articles
-
[Tumorogenesis and mdm2 protein].Rev Med Chil. 2000 May;128(5):539-46. Rev Med Chil. 2000. PMID: 11008360 Review. Spanish.
-
Limited role of N-terminal phosphoserine residues in the activation of transcription by p53.Oncogene. 2004 May 27;23(25):4477-87. doi: 10.1038/sj.onc.1207575. Oncogene. 2004. PMID: 15064747
-
Mdmx as an essential regulator of p53 activity.Biochem Biophys Res Commun. 2005 Jun 10;331(3):750-60. doi: 10.1016/j.bbrc.2005.03.151. Biochem Biophys Res Commun. 2005. PMID: 15865931 Review.
-
Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53.Nature. 1995 Nov 9;378(6553):203-6. doi: 10.1038/378203a0. Nature. 1995. PMID: 7477326
-
Nuclear exclusion of p53 in a subset of tumors requires MDM2 function.Oncogene. 2000 Jan 13;19(2):232-40. doi: 10.1038/sj.onc.1203262. Oncogene. 2000. PMID: 10645001
Cited by
-
Biomarkers in advanced larynx cancer.Laryngoscope. 2014 Jan;124(1):179-87. doi: 10.1002/lary.24245. Epub 2013 Jul 12. Laryngoscope. 2014. PMID: 23775802 Free PMC article.
-
Effects of serum containing Chinese medicine Sanpi Pingwei () formula on proliferation and apoptosis of human SGC-7901 cells.Chin J Integr Med. 2013 Feb;19(2):119-26. doi: 10.1007/s11655-012-1208-6. Epub 2012 Sep 21. Chin J Integr Med. 2013. PMID: 23001460
-
Exploiting Oncogenic Drivers along the CCNG1 Pathway for Cancer Therapy and Gene Therapy.Mol Ther Oncolytics. 2018 Dec 12;11:122-126. doi: 10.1016/j.omto.2018.11.002. eCollection 2018 Dec 21. Mol Ther Oncolytics. 2018. PMID: 30581985 Free PMC article. Review. No abstract available.
-
Increased E2F1 activity induces skin tumors in mice heterozygous and nullizygous for p53.Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8858-63. doi: 10.1073/pnas.95.15.8858. Proc Natl Acad Sci U S A. 1998. PMID: 9671769 Free PMC article.
-
Synthesis and Antineoplastic Activity of a Dimer, Spiroindolinone Pyrrolidinecarboxamide.Molecules. 2023 May 5;28(9):3912. doi: 10.3390/molecules28093912. Molecules. 2023. PMID: 37175323 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous